Back to Journals » Clinical Interventions in Aging » Volume 8

Optimal treatment of actinic keratoses

Authors Uhlenhake E

Received 30 October 2012

Accepted for publication 4 December 2012

Published 14 January 2013 Volume 2013:8 Pages 29—35

DOI https://doi.org/10.2147/CIA.S31930

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Elizabeth E Uhlenhake

Department of Dermatology, Wayne State University School of Medicine, Detroit, MI, USA


Abstract: The most compelling reason and primary goal of treating actinic keratoses is to prevent malignant transformation into invasive squamous cell carcinoma, and although there are well established guidelines outlining treatment modalities and regimens for squamous cell carcinoma, the more commonly encountered precancerous actinic lesions have no such standard. Many options are available with variable success and patient compliance rates. Prevention of these lesions is key, with sun protection being a must in treating aging patients with sun damage as it is never too late to begin protecting the skin.

Keywords: actinic keratosis, photodynamic therapy, topical chemotherapy, field therapy

A Letter to the Editor has been received and published for this article.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]